Celgene
Celgene discovers, develops and commercializes innovative therapies to treat cancer and immune-inflammatory-related diseases.
3
Funding Rounds
$34.7m
Money raised
| Name | Phone | Social networks | |
|---|---|---|---|
| Ro**** Ha**** |
|
- | linkedin twitter |
| So* Ba*** | - | - | - |
| Name | Phone | Social networks | |
|---|---|---|---|
| Ri***** Ba**** | - | - | - |
| Ja******* A. Fo*** | - | - | - |
| ca**** co* | - | - | |
| Er**** Ma*** | - | - | - |
| Mi***** Ca*** | - | - | - |
| Mi***** Bo**** | - | - | - |
| Name | Phone | Social networks | |
|---|---|---|---|
| Ro**** J. Hu*** |
|
- | |
| Ma** J. Al*** | - | - |
| Name | Phone | Social networks | |
|---|---|---|---|
| Ro**** J. Hu*** |
|
- |
Funding
Funding series
Funding Series Analysis
The company Celgene has raised a total of $34.65m in funding over 3 rounds.
Key Insights:
- Celgene funding round, February 2012: $15m
- Celgene Series B round: $12.4m
- Celgene Series A round: $7.25m
Celgene funding round, February 2012
$15m
Celgene Series B round
$12.4m
Celgene Series A round
$7.25m
Industries
Celgene is active in the following industries:
- Internal medicine
- Medicine
- Biotechnology
- Biology
- Healthcare
- Technology
- Cancer immunotherapy
- Oncology
- Epigenetics
- Therapeutics
- Biopharmaceutical
- Immunotherapy
- Therapy
- Ageing
- Drug discovery
- Autoimmune disease
- Pharmaceutical industry
Subsidiaries
Celgene operates through the following subsidiaries:
